Table 2.
Compound | IC50 (μM)1 |
---|---|
BHT (positive control) | 98.8 ± 4.5 |
BHA (positive control) | 105.4 ± 5.3 |
4-ketopinoresinol (3) | 143.3 ± 13.1 |
8α-hydroxypinoresinol (4) | 71.5± 5.9 |
9α-hydroxypinoresinol | 84.0± 2.9 |
Abietin | >500 |
apigenin-7-O-a-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (isorhoifolin) | >500 |
chlorogenic acid | 59.8 ± 4.9 |
Ciwujiatone | 64.7 ± 5.3 |
erythro-guaiacylglycerol-β-O-4′-dihydroconiferyl alcohol | >500 |
kaempferol-3-O-α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (biorobin) | 39.4 ± 2.8 |
luteolin 4′-O-glucuronide | 38.9 ± 2.5 |
naringenin-7-O-neohesperidoside | 116.0 ± 9.7 |
neochlorogenic acid | 65.8 ± 4.8 |
nortrachelogenin (1) | 38.6 ± 2.7 |
nortrachelogenin-4,4′-di-O-β-D-glucopyranoside (2) | 34.4 ± 2.3 |
pinoresinol | 50.8 ± 3.1 |
quercetin-3-O-α-l-rhamnopyranosyl-(1→6)-β-D-glucopyranoside (rutin) | 63.0 ± 4.6 |
quercitrin | 12.2 ± 1.0 |
sinapic aldehyde | 53.4 ± 3.8 |
1Values represent averages ± standard deviations for triplicate experiments.